β€’
Jun 30, 2022

Healthpeak Q2 2022 Earnings Report

Announced results for the second quarter ended June 30, 2022

Key Takeaways

Healthpeak Properties reported second quarter results, including net income of $0.13 per share, Nareit FFO of $0.44 per share, and blended Total Same-Store Portfolio Cash (Adjusted) NOI growth of 3.7%.

Net income of $0.13 per share, Nareit FFO of $0.44 per share, FFO as Adjusted of $0.44 per share, and blended Total Same-Store Portfolio Cash (Adjusted) NOI growth of 3.7%.

Life Science and MOB Same-Store Portfolio Cash (Adjusted) NOI growth of 4.3% and 4.5%, respectively.

Announced a $500 million share repurchase program.

Net debt to adjusted EBITDAre and liquidity were 5.1x and $2.0 billion, respectively, as of June 30, 2022.

Total Revenue
$132M
Previous year: $113M
+17.0%
EPS
$0.27
Previous year: $0.26
+3.8%
Gross Profit
$303M
Previous year: $286M
+5.9%
Cash and Equivalents
$73M
Previous year: $96.9M
-24.7%
Total Assets
$15.3B
Previous year: $14.3B
+6.9%

Healthpeak

Healthpeak

Healthpeak Revenue by Segment

Forward Guidance

Reaffirming and updating guidance ranges for full year 2022.

Positive Outlook

  • Diluted earnings per common share from $0.58 – $0.64 to $0.97 – $1.03
  • Total Portfolio Same-Store Cash (Adjusted) NOI growth Guidance from 3.25% – 4.75% to 3.50% – 5.00%